February 4, 2022
The novel investigational peptide inhibitor zilucoplan (UCB) continues to show promise in the treatment of adults with generalized myasthenia gravis (gMG). Top-line results from the phase […]
February 4, 2022
Drinking alcohol is linked to an increased risk of new-onset epilepsy, with greater consumption tied to greater risk, but more research is needed before any definitive […]
February 4, 2022
The study covered in this summary was published as a preprint and has not yet been peer-reviewed. Key Takeaways Clinical, environmental, and genetic risk measures show […]
February 3, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Using a novel force […]
February 3, 2022
This study was published as a preprint and has not yet been peer reviewed. Key Takeaways Variants in ATP8B4 and ABCA1 were identified as novel risk […]
February 3, 2022
A younger age, the presence of comorbidities, and female sex are all factors associated with an increased risk for COVID-19 in patients with multiple sclerosis (MS), […]
February 3, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Fatigue imposes a significant […]
February 1, 2022
Native American tribes have reached settlements over the toll of opioids totaling $590 million with drugmaker Johnson & Johnson and the country’s three largest drug distribution […]
January 31, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Higher genetic risk of […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131
Next page